Data from Circulating Biomarkers of Tryptophan and the Kynurenine Pathway and Lung Cancer Risk

Shu‐Chun Chuang; Anouar Fanidi; Per Magne Ueland; Caroline L. Relton; Øivind Midttun; Dan Joseph Stein; Marc J. Gunter; Michael J. Seckl; Ruth C. Travis; Nicholas J. Wareham; Antonia Trichopoulou; Παγώνα Λάγιου; Dimitrios Trichopoulos; Petra H. Peeters; H. Bas Bueno-de-Mesquita; Heiner Boeing; Angelika Wientzek; Tilman Küehn; Rudolf Kaaks; ­Rosario ­Tumino; Claudia Agnoli; Domenico Palli; Alessio Naccarati; Eva Ardanáz; María‐José Sánchez; J. Ramón Quirós; María‐Dolores Chirlaque; Antonio Agudo; Mikael Johansson; Kjell Grankvist; Marie‐Christine Boutron‐Ruault; Françoise Clavel-Chapelon; Guy Fagherazzi; Elisabete Weiderpass; Elio Ríboli; Paul Brennan; Paolo Vineis; Mattias Johansson

doi:10.1158/1055-9965.c.6515694.v1

Abstract

1 min read

<div>AbstractBackground: Imbalances in tryptophan metabolism have been linked to cancer-related immune escape and implicated in several cancers, including lung cancer.Methods: We conducted a nested case–control study within the European Prospective Investigation into Cancer and Nutrition (EPIC) that included 893 incident lung cancer cases and 1,748 matched controls. Circulating levels of tryptophan and six of its metabolites were measured and evaluated in relation to lung cancer risk.Results: Tryptophan (Ptrend = 2 × 10−5) and the kynurenine/tryptophan ratio (KTR; Ptrend = 4 × 10−5) were associated with lung cancer risk overall after adjusting for established risk factors. The ORs comparing the fifth and first quintiles (OR5th vs. 1st) were 0.52 [95% confidence interval (CI), 0.37–0.74] for tryptophan and 1.74 (95% CI, 1.24–2.45) for KTR. After adjusting for plasma methionine (available from previous work, which was strongly correlated with tryptophan), the associations of tryptophan (adjusted Ptrend = 0.13) and KTR (Ptrend = 0.009) were substantially attenuated. KTR was positively associated with squamous cell carcinoma, the OR5th vs. 1st being 2.83 (95% CI, 1.62–4.94, Ptrend = 3 × 10−5) that was only marginally affected by adjusting for methionine.Conclusions: This study indicates that biomarkers of tryptophan metabolism are associated with subsequent lung cancer risk. Although this result would seem consistent with the immune system having a role in lung cancer development, the overall associations were dependent on methionine, and further studies are warranted to further elucidate the importance of these metabolites in lung cancer etiology.Impact: This is the first prospective study investigating the tryptophan pathway in relation to lung cancer risk. Cancer Epidemiol Biomarkers Prev; 23(3); 461–8. ©2013 AACR.</div>

Related publications

Preprint2023